Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ADALIMUMAB-AFZB Cause Device delivery system issue? 21 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Device delivery system issue have been filed in association with ADALIMUMAB-AFZB (ABRILADA). This represents 1.0% of all adverse event reports for ADALIMUMAB-AFZB.

21
Reports of Device delivery system issue with ADALIMUMAB-AFZB
1.0%
of all ADALIMUMAB-AFZB reports
0
Deaths
2
Hospitalizations

How Dangerous Is Device delivery system issue From ADALIMUMAB-AFZB?

Of the 21 reports, 2 (9.5%) required hospitalization.

Is Device delivery system issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB-AFZB. However, 21 reports have been filed with the FAERS database.

What Other Side Effects Does ADALIMUMAB-AFZB Cause?

Off label use (748) Condition aggravated (533) Drug ineffective (254) Fatigue (231) Arthralgia (190) Pain (170) Injection site pain (159) Drug dose omission by device (116) Nausea (115) Headache (113)

What Other Drugs Cause Device delivery system issue?

ALBUTEROL (9,509) SOMATROPIN (1,848) EXENATIDE (1,533) BUDESONIDE\FORMOTEROL (1,260) BUDESONIDE\FORMOTEROL\GLYCOPYRROLATE (1,181) BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM (523) LEVALBUTEROL (459) MOMETASONE FUROATE\OLOPATADINE (347) ABATACEPT (342) PEGFILGRASTIM (323)

Which ADALIMUMAB-AFZB Alternatives Have Lower Device delivery system issue Risk?

ADALIMUMAB-AFZB vs ADALIMUMAB-ATTO ADALIMUMAB-AFZB vs ADALIMUMAB-BWWD ADALIMUMAB-AFZB vs ADALIMUMAB-FKJP ADALIMUMAB-AFZB vs ADALIMUMAB-RYVK ADALIMUMAB-AFZB vs ADALIMUMAB\ISOPROPYL ALCOHOL

Related Pages

ADALIMUMAB-AFZB Full Profile All Device delivery system issue Reports All Drugs Causing Device delivery system issue ADALIMUMAB-AFZB Demographics